JO3440B1 - استخدام الأغوميلاتين في تحضير علاجات لمداولة اضطرابات القلق العام. - Google Patents

استخدام الأغوميلاتين في تحضير علاجات لمداولة اضطرابات القلق العام.

Info

Publication number
JO3440B1
JO3440B1 JOP/2007/0119A JOP20070119A JO3440B1 JO 3440 B1 JO3440 B1 JO 3440B1 JO P20070119 A JOP20070119 A JO P20070119A JO 3440 B1 JO3440 B1 JO 3440B1
Authority
JO
Jordan
Prior art keywords
agomelatine
treatment
anxiety disorder
generalized anxiety
medicaments intended
Prior art date
Application number
JOP/2007/0119A
Other languages
English (en)
Inventor
Fabiano Agnes
Mocaer Elisabeth
Delalleau Bruno
Millan Mark
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37308935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JO3440(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of JO3440B1 publication Critical patent/JO3440B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

يتعلق الاختراع الحالي باستخدام الأغوميلاتين, أو ن[2-(7-متوكسي-1-نفثيل)إيثيل]أسيتاميد, في الحصول على علاج لمتلازمة القلق العام.
JOP/2007/0119A 2006-04-07 2007-04-05 استخدام الأغوميلاتين في تحضير علاجات لمداولة اضطرابات القلق العام. JO3440B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603083A FR2899472B1 (fr) 2006-04-07 2006-04-07 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee

Publications (1)

Publication Number Publication Date
JO3440B1 true JO3440B1 (ar) 2019-10-20

Family

ID=37308935

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2007/0119A JO3440B1 (ar) 2006-04-07 2007-04-05 استخدام الأغوميلاتين في تحضير علاجات لمداولة اضطرابات القلق العام.

Country Status (44)

Country Link
US (1) US7960438B2 (ar)
EP (1) EP1842535B1 (ar)
JP (1) JP4880031B2 (ar)
KR (1) KR20070100657A (ar)
CN (1) CN101049290B (ar)
AP (1) AP2488A (ar)
AR (1) AR060349A1 (ar)
AT (1) ATE477798T1 (ar)
AU (1) AU2007201527B2 (ar)
BR (1) BRPI0701601A (ar)
CA (1) CA2584060C (ar)
CO (1) CO5840252A1 (ar)
CR (1) CR9019A (ar)
CY (1) CY1111287T1 (ar)
DE (1) DE602007008494D1 (ar)
DK (1) DK1842535T3 (ar)
EA (1) EA012608B1 (ar)
ES (1) ES2351062T3 (ar)
FR (1) FR2899472B1 (ar)
GE (1) GEP20094743B (ar)
GT (1) GT200700032A (ar)
HK (1) HK1108367A1 (ar)
HR (1) HRP20100577T1 (ar)
IL (1) IL182407A (ar)
JO (1) JO3440B1 (ar)
MA (1) MA28987B1 (ar)
ME (1) ME01865B (ar)
MX (1) MX2007004100A (ar)
MY (1) MY143269A (ar)
NI (1) NI200700084A (ar)
NO (1) NO20071774L (ar)
NZ (1) NZ554347A (ar)
PE (1) PE20080174A1 (ar)
PL (1) PL1842535T3 (ar)
PT (1) PT1842535E (ar)
RS (1) RS51485B (ar)
SA (1) SA07280161B1 (ar)
SG (1) SG136881A1 (ar)
SI (1) SI1842535T1 (ar)
TN (1) TNSN07118A1 (ar)
TW (1) TWI374736B (ar)
UY (1) UY30262A1 (ar)
WO (1) WO2007116136A1 (ar)
ZA (1) ZA200702865B (ar)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
CN101585779B (zh) * 2009-03-10 2014-04-02 上海医药工业研究院 阿戈美拉汀的晶型vi及其制备方法和应用
FR2956031B1 (fr) * 2010-02-11 2012-03-02 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc)
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
PH12012000132A1 (en) * 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
PT2810656T (pt) 2013-06-06 2017-11-13 Zentiva As Formulações de agomelatina compreendendo agomelatina na forma de cocristais
IT201900002913A1 (it) 2019-03-01 2020-09-01 Nicola Pescosolido Composto utile per il trattamento del glaucoma
CN110867197A (zh) * 2019-10-23 2020-03-06 吴杰 语音交互过程中实时打断语音机器人的方法及设备

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
SG45100A1 (en) * 1994-03-07 1998-01-16 Ibm Improvements in image processing
DE19532842C1 (de) * 1995-09-05 1996-12-19 Ibm Bildaufnahmesystem
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
JP2007517040A (ja) * 2003-12-24 2007-06-28 セプレイコー インコーポレイテッド 睡眠の質を改善するためのメラトニン併用療法
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
CA2599937A1 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7635721B2 (en) * 2005-08-03 2009-12-22 Les Laboratoires Servier Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200735878A (en) * 2005-11-18 2007-10-01 Astrazeneca Ab Pharmaceutical compositions

Also Published As

Publication number Publication date
ES2351062T3 (es) 2011-01-31
FR2899472B1 (fr) 2008-09-12
TNSN07118A1 (fr) 2008-06-02
US20070238792A1 (en) 2007-10-11
TW200808295A (en) 2008-02-16
CA2584060A1 (fr) 2007-10-07
EA200700574A3 (ru) 2007-12-28
MA28987B1 (fr) 2007-11-01
SI1842535T1 (sl) 2010-10-29
CN101049290B (zh) 2012-10-31
EP1842535A1 (fr) 2007-10-10
BRPI0701601A (pt) 2007-12-11
MX2007004100A (es) 2009-02-16
AP2488A (en) 2012-10-03
DK1842535T3 (da) 2010-11-15
AU2007201527B2 (en) 2012-08-09
ME01865B (me) 2011-04-30
CN101049290A (zh) 2007-10-10
HRP20100577T1 (hr) 2010-11-30
PL1842535T3 (pl) 2011-01-31
IL182407A0 (en) 2008-01-20
CR9019A (es) 2008-10-28
GEP20094743B (en) 2009-07-27
DE602007008494D1 (de) 2010-09-30
EA200700574A2 (ru) 2007-10-26
WO2007116136A1 (fr) 2007-10-18
NZ554347A (en) 2008-08-29
JP4880031B2 (ja) 2012-02-22
SG136881A1 (en) 2007-11-29
MY143269A (en) 2011-04-15
EP1842535B1 (fr) 2010-08-18
AP2007003953A0 (en) 2007-04-30
JP2009532446A (ja) 2009-09-10
UY30262A1 (es) 2007-05-31
ATE477798T1 (de) 2010-09-15
FR2899472A1 (fr) 2007-10-12
SA07280161B1 (ar) 2010-10-23
PT1842535E (pt) 2010-09-28
NI200700084A (es) 2008-04-24
TWI374736B (en) 2012-10-21
US7960438B2 (en) 2011-06-14
AU2007201527A1 (en) 2007-10-25
GT200700032A (es) 2007-10-31
KR20070100657A (ko) 2007-10-11
CY1111287T1 (el) 2015-08-05
HK1108367A1 (en) 2008-05-09
EA012608B1 (ru) 2009-10-30
RS51485B (en) 2011-04-30
CO5840252A1 (es) 2007-12-31
CA2584060C (fr) 2011-04-26
PE20080174A1 (es) 2008-03-29
NO20071774L (no) 2007-10-08
ZA200702865B (en) 2008-07-30
IL182407A (en) 2016-02-29
AR060349A1 (es) 2008-06-11

Similar Documents

Publication Publication Date Title
JO3440B1 (ar) استخدام الأغوميلاتين في تحضير علاجات لمداولة اضطرابات القلق العام.
EA200601449A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения нарушений сна у пациента с депрессией
JO2656B1 (ar) استخدام الاغوميلاتين للحصول على ادوية لعلاج متلازمة سميث ماغينيس سيندروم
DK2079735T3 (da) N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl-(1-(thiazol-4-ylmethyl)-piperidin-4-yliden)-methyl)-benzamid, fremgangsmåde til fremstilling heraf samt anvendelse heraf til behandling af smerter, angst og depression
TW200716083A (en) Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
EA201201123A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения обсессивно-компульсивного расстройства (окр)
JO2631B1 (ar) استخدام الاغوميلاتين للحصول على ادوية لعلاج تلين المادة البيضاء حول بطينات الدماغ
UA88322C2 (ru) Применение агомелатина как единственного активного агента в получении лекарственных средств, предназначенных для лечения генерализованного тревожного расстройства
CU20070070A7 (es) Composición farmacéutica de agomelatina
CU20070232A7 (es) Utilización de la agomelatina para la obtención de medicamentos destinados al tratamiento de los trastornos bipolares